Kinetic analysis of hepatobiliary transport of drugs: Importance of carrier-mediated transport

被引:4
|
作者
Yamazaki, M
Nishigaki, R
Suzuki, H
Sugiyama, Y
机构
[1] UNIV TOKYO, FAC PHARMACEUT SCI, BUNKYO KU, TOKYO 113, JAPAN
[2] TOHO UNIV, SCH PHARMACEUT SCI, DEPT PHARMACOKINET & BIOPHARMACEUT, FUNABASHI, CHIBA 274, JAPAN
关键词
organic anion; bile acid; primary active transport; multispecific anion transporter; Eisai hyperbilirubinemic rat;
D O I
10.1248/yakushi1947.115.12_953
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The liver is the major organ involved in the metabolism and elimination of xenobiotics. Evaluating accurately hepatic clearance is very important for predicting the pharmacological effect and/or side-effects of drugs, as well as changes in drug disposition during disease. Recently, for many endogenous and exogenous compounds (including drugs), it has been reported that carrier-mediated transport contributes to hepatic uptake and/or biliary excretion. In particular, primary active transport mechanisms have been shown to be responsible for the biliary excretion of anticancer drugs, endogenous bile acids and organic anions including glutathione and glucuronic acid conjugates. We have found that a rate-limiting step for several drugs in terms of the hepatic clearance was the membrane transport process. For these drugs, such a saturable transport process can be one of the major determinants which influence not only hepatic clearance itself but also disposition (in other words, plasma elimination) in the whole body. We reviewed the carrier-mediated transport mechanisms involved in the hepatic uptake and biliary excretion processes, the multiplicity of transport systems, and further, the physiological meaning of these complex transport systems in the body.
引用
收藏
页码:953 / 977
页数:25
相关论文
共 50 条
  • [21] Carrier-mediated transport of clonidine in human keratinocytes
    Grafe, F
    Wohlrab, W
    Neubert, R
    Brandsch, M
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (2-3) : 309 - 312
  • [22] CARRIER-MEDIATED TRANSPORT OF OUABAIN IN ISOLATED HEPATOCYTES
    EATON, DL
    KLAASSEN, CD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1978, 205 (02): : 480 - 488
  • [23] Carrier-mediated transport of riboflavin in Ashbya gossypii
    Applied Microbiology and Biotechnology, 2001, 55 : 85 - 89
  • [24] Carrier-mediated or specialized transport of drugs across the blood-brain barrier
    Tsuji, A
    Tamai, I
    ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (2-3) : 277 - 290
  • [25] LIVER BROMOSULFONPHTHALEIN TRANSPORT AS A CARRIER-MEDIATED PROCESS
    TIRIBELLI, C
    FREZZA, M
    PANFILI, E
    SANDRI, G
    SOTTOCASA, GL
    RENDICONTI DI GASTRO-ENTEROLOGIA, 1975, 7 (03): : 218 - 219
  • [26] CARRIER-MEDIATED TRANSPORT OF FOLATE BY HUMAN ERYTHROCYTES
    BRANDA, RF
    ANTHONY, BK
    JACOB, HS
    BLOOD, 1976, 48 (06) : 992 - 992
  • [27] Carrier-mediated transport of riboflavin in the rat colon
    Yuasa, H
    Hirobe, M
    Tomei, S
    Watanabe, J
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2000, 21 (02) : 77 - 82
  • [28] CARRIER-MEDIATED TRANSPORT OF DOXORUBICIN IN CARDIOMYOCYTES.
    Huang, K. M.
    Magdy, T.
    Hu, S.
    Gibson, A. A.
    Sparreboom, A.
    Burridge, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S37 - S37
  • [29] Carrier-mediated Transport of Cationic Drugs across the Blood-Tissue Barrier
    Kubo, Yoshiyuki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2015, 135 (10): : 1135 - 1140
  • [30] CARRIER-MEDIATED TRANSPORT OF FOLATE BY HUMAN ERYTHROCYTES
    BRANDA, RF
    ANTHONY, BK
    JACOB, HS
    CLINICAL RESEARCH, 1976, 24 (04): : A539 - A539